Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Saltillo
Clinical trial register · Mexico

Clinical Trials in Saltillo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
1585
Studies in scope
all four open statuses
704
Recruiting now
open to new participants
247
Lead sponsors
across recruiting studies
Top sites
Mexico City 600 Monterrey 378 Guadalajara 344 Chihuahua City 177 Mérida 128

Trials with a site in Saltillo

13 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Saltillo, Celaya, Tlajomulco de Zúñiga
2026-06-08
Recruiting
Bristol-Myers Squibb
Phase 3
850
Saltillo, Tijuana, Zapopan, Monterrey, Puebla City, Querétaro
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
650
Saltillo, Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Tlalnepantla
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
426
Saltillo, Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Tlalnepantla
2025-07-10
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Saltillo, Celaya, Tlajomulco de Zúñiga, Coyoacán, Querétaro
2025-05-27
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Saltillo, Mexico City, Pachuca, Guadalajara, Monterrey, Puebla City, Veracruz
2025-04-24
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Saltillo, Morelia, Monterrey
2023-02-02
Active, closed
Celcuity Inc
Phase 3
701
Mexico City, Monterrey, Morelia, Nuevo León, Querétaro, Saltillo
2022-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Chihuahua City, Guadalajara, Mexico City, Mérida, Monterrey, Saltillo, San Pedro Garza García
2022-09-13
Active, closed
Bristol-Myers Squibb
Phase 3
670
Saltillo, Guadalajara, Mexico City, San Luis Potosí City, Mérida, Chihuahua City, Veracruz
2021-07-13
Active, closed
Hoffmann-La Roche
Phase 3
746
Saltillo, Mexico City, Culiacán, Mexico
2021-03-17
Active, closed
OBI Pharma, Inc
Phase 3
575
Saltillo, Mexico City, Zapopan, Morelia, San Pedro Garza García, Toluca, Aguascalientes, Chihuahua City
2018-12-05
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-mexico/city/saltillo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Saltillo.

How many clinical trials are recruiting in Saltillo?

5 of the 13 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Saltillo), 13 studies
PhaseStudiesRecruitingShare
Phase 310476.9%
Phase 23123.1%

Most active sponsors

Lead sponsors with the most studies (Saltillo)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb43
Spyre Therapeutics, Inc.21
Celcuity Inc10
Hoffmann-La Roche10
Janssen Research & Development, LLC10
Mirati Therapeutics Inc.11
Novartis Pharmaceuticals10
OBI Pharma, Inc10
Sanofi10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.